Last reviewed · How we verify

Allergen immunotherapy

Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C. · Phase 2 active Biologic

Allergen immunotherapy works by gradually increasing exposure to specific allergens to build tolerance and reduce symptoms.

Allergen immunotherapy works by gradually increasing exposure to specific allergens to build tolerance and reduce symptoms. Used for Treatment of allergic rhinitis and asthma.

At a glance

Generic nameAllergen immunotherapy
SponsorRohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.
Drug classImmunomodulator
ModalityBiologic
Therapeutic areaImmunology
PhasePhase 2

Mechanism of action

This is achieved through subcutaneous injections or sublingual tablets that contain small amounts of the allergen, allowing the body to develop a protective immune response and reduce inflammation.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: